Saturday, March 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home News Scan

Biodefense Headlines – August 9, 2015

by Global Biodefense Staff
August 9, 2015
Global Biodefense News - Anthrax

Global Biodefense News - AnthraxResponsible use of pop culture and communication in the face of Ebola | U.N. Security Council adopts measure to identify chlorine bomb users in Syria | Emergent BioSolutions plans to spin-off biosciences company | Ebola survivor meeting explores research priorities, ‘biobanking’ | Rapid response kept Ohio botulism outbreak in check | New York cooling towers to be tested as Legionnaires’ deaths hit 10 | Outgoing HHMI chief reflects on leading $18 billion biomedical charity | What ‘100 percent effective’ means for that Ebola vaccine | U.S. health regulator issues new cleaning guide for superbug-prone device | CDC’s plan to reduce superbug infections is wishful thinking | Trial sheds light on lower VSV-EBOV doses | Ebola survivors face lingering pain, fatigue and depression | Polio vaccination programs face challenges in high-conflict areas | California child diagnosed with plague after Yosemite trip

See what we’re reading this week at Global Biodefense on topics including Legionnaires’ in New York, long-term health challenges for Ebola survivors, and plague in Yosemite.

Responsible use of pop culture and communication in the face of Ebola (PLOS)

U.N. Security Council adopts measure to identify chlorine bomb users in Syria (NY Times)

Emergent BioSolutions plans to spin-off biosciences company (Washington Post)

Ebola survivor meeting explores research priorities, ‘biobanking’ (CIDRAP)

Rapid response kept Ohio botulism outbreak in check (Food Safety News)

New York cooling towers to be tested as Legionnaires’ deaths hit 10 (Reuters)

Outgoing HHMI chief reflects on leading $18 billion biomedical charity (Science)

What ‘100 percent effective’ means for that Ebola vaccine (Wired)

U.S. health regulator issues new cleaning guide for superbug-prone device (Reuters)

CDC’s plan to reduce superbug infections is wishful thinking (Forbes)

Trial sheds light on lower VSV-EBOV doses (CIDRAP)

Ebola survivors face lingering pain, fatigue and depression (NY Times)

Polio vaccination programs face challenges in high-conflict areas (Healio)

California child diagnosed with plague after Yosemite trip (Reuters)

Related Posts

Biodefense Headlines – 12 March 2023
News Scan

Biodefense Headlines – 12 March 2023

March 12, 2023
Biodefense Headlines – 24 January 2023
News Scan

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023
News Scan

Biodefense Headlines – 17 January 2023

January 17, 2023
Biodefense Headlines – 10 January 2023
News Scan

Biodefense Headlines – 10 January 2023

January 10, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC